1. ANTI-SARS-COV-2 VACCINATION AND ANTIBODY RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON IMMUNE-MODIFYING THERAPY. PROSPECTIVE SINGLE TERTIARY CENTER STUDY ON 602 IBD PATIENTS. (22nd January 2022) Authors: Cerna, Karin; Duricova, Dana; Lukas, Martin; Machkova, Nadezda; Hruba, Veronika; Lukas, Milan Journal: Inflammatory bowel diseases Issue: Volume 28(2022)Supplement 1 Page Start: S101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anti-SARS-CoV-2 Vaccination and Antibody Response in Patients With Inflammatory Bowel Disease on Immune-modifying Therapy: Prospective Single-Tertiary Study. Issue 10 (30th November 2021) Authors: Cerna, Karin; Duricova, Dana; Lukas, Martin; Machkova, Nadezda; Hruba, Veronika; Mitrova, Katarina; Kubickova, Kristyna; Kostrejova, Marta; Teplan, Vladimir; Vasatko, Martin; Kastylova, Kristyna; Lukas, Milan Journal: Inflammatory bowel diseases Issue: Volume 28:Issue 10(2022) Page Start: 1506 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cellular and Humoral Immune Responses to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease Patients. (31st March 2022) Authors: Cerna, Karin; Duricova, Dana; Hindos, Miroslav; Hindos Hrebackova, Jana; Lukas, Martin; Machkova, Nadezda; Hruba, Veronika; Mitrova, Katarina; Kubickova, Kristyna; Kastylova, Kristyna; Teplan, Vladimir; Lukas, Milan Journal: Journal of Crohn's and colitis Issue: Volume 16:Number 9(2022) Page Start: 1347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Discontinuation of anti-tumor necrosis factor therapy in inflammatory bowel disease patients: a prospective observation. (1st February 2016) Authors: Bortlik, Martin; Duricova, Dana; Machkova, Nadezda; Hruba, Veronika; Lukas, Martin; Mitrova, Katarina; Romanko, Igor; Bina, Vladislav; Malickova, Karin; Kolar, Martin; Lukas, Milan Journal: Scandinavian journal of gastroenterology Issue: Volume 51:Number 2(2016) Page Start: 196 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. DUAL BIOLOGICAL OR SMALL MOLECULE TREATMENT IN INFLAMMATORY BOWEL DISEASES: DATA FROM CLINICAL PRACTICE. (22nd January 2022) Authors: Lukas, Milan; Kolar, Martin; Vasatko, Martin; Lukas, Martin; Duricova, Dana; Machkova, Nadezda; Hruba, Veronika; Cerna, Karin; Kastylova, Kristyna; Kubickova, Kristyna Journal: Inflammatory bowel diseases Issue: Volume 28(2022)Supplement 1 Page Start: S105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. EFFICIENCY OF DUAL THERAPY WITH VEDOLIZUMAB AND TOFACITINIB IN REFRACTORY ULCERATIVE COLITIS PATIENTS – SINGLE CENTRE EXPERIENCE. (26th January 2023) Authors: Kolar, Martin; Kastylova, Kristyna; Lukas, Martin; Duricova, Dana; Hruba, Veronika; Machkova, Nadezda; Cerna, Karin; Jirsa, Jakub; Kubickova, Kristyna; Vojtechova, Gabriela; Lukas, Milan Journal: Inflammatory bowel diseases Issue: Volume 29(2023)Supplement 1 Page Start: S78 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Endoscopic evaluation of surgically altered bowel in inflammatory bowel disease: a consensus guideline from the Global Interventional Inflammatory Bowel Disease Group. (June 2021) Authors: Shen, Bo; Kochhar, Gursimran S; Navaneethan, Udayakumar; Cross, Raymond K; Farraye, Francis A; Iacucci, Marietta; Schwartz, David A; Gonzalez-Lama, Yago; Schairer, Jason; Kiran, Ravi P; Kotze, Paulo Gustavo; Kobayashi, Taku; Bortlik, Martin; Liu, Xiuli; Levy, Alexander N; González Suárez, Begoña;... Journal: Lancet gastroenterology and hepatology Issue: Volume 6:Number 6(2021) Page Start: 482 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. ENDOSCOPIC STRICTUROTOMY – A NOVEL THERAPEUTIC MODALITY FOR IBD-RELATED STRICTURES: FIRST EUROPEAN EXPERIENCE. (22nd January 2022) Authors: Lukas, Martin; Kolar, Martin; Vasatko, Martin; Lukas, Milan Journal: Inflammatory bowel diseases Issue: Volume 28(2022)Supplement 1 Page Start: S40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort. Issue 8 (3rd August 2017) Authors: Bálint, Anita; Rutka, Mariann; Végh, Zsuzsanna; Kürti, Zsuzsanna; Gecse, Krisztina B.; Banai, János; Bene, László; Gasztonyi, Beáta; Kristóf, Tünde; Lakatos, László; Miheller, Pál; Palatka, Károly; Patai, Árpád; Salamon, Ágnes; Szamosi, Tamás; Szepes, Zoltán; Tóth, Gábor Tamás; Vincze, Áron; Bor,... Journal: Expert opinion on drug safety Issue: Volume 16:Issue 8(2017:Aug.) Page Start: 885 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis – results from multicenter observational cohort. (2nd November 2018) Authors: Bálint, Anita; Rutka, Mariann; Kolar, Martin; Bortlik, Martin; Duricova, Dana; Hruba, Veronika; Lukas, Martin; Mitrova, Katarina; Malickova, Karin; Lukas, Milan; Szepes, Zoltán; Nagy, Ferenc; Palatka, Károly; Lovas, Szilvia; Végh, Zsuzsanna; Kürti, Zsuzsanna; Csontos, Ágnes; Miheller, Pál; Nyári,... Journal: Expert opinion on biological therapy Issue: Volume 18:Number 11(2018) Page Start: 1181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗